Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups

Leukemia

Volumn 28, Issue 6, 2014, Pages 1352-1355

  Pillozzi, S ^a   Accordi, B ^b   Rebora, P ^c   Serafin, V ^b   Valsecchi, M G ^c   Basso, G ^b   Arcangeli, A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HERG1A PROTEIN; HERG1B PROTEIN; MESSENGER RNA; POTASSIUM CHANNEL HERG; PREDNISONE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; POTASSIUM CHANNEL HERG1A; POTASSIUM CHANNEL HERG1B;

ACUTE LYMPHOBLASTIC LEUKEMIA; B CELL LEUKEMIA; CANCER PROGNOSIS; CANCER RECURRENCE; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOPHENOTYPING; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T CELL LEUKEMIA; UPREGULATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL MOTILITY; CHILDHOOD CANCER; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; EVENT FREE SURVIVAL; GENE OVEREXPRESSION; HAZARD RATIO; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA RELAPSE; LONG TERM SURVIVAL; NONHUMAN; PEDIATRICS; PREDICTIVE VALUE; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

CHILD, PRESCHOOL; COHORT STUDIES; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; HUMANS; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; PEDIATRICS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84902085305     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.26     Document Type: Letter

References (16)

1. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care 2005; 14: 53-62. (Pubitemid 40314386)
2. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354: 166-178. (Pubitemid 43076714)
3. Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L et al. Childhood T-cell acute lymphoblastic leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium experience. J Clin Oncol 2003; 21: 3616-3622. (Pubitemid 46594054)
4. Sanguinetti MC, Tristani-Firouzi M. hERG potassium channels and cardiac arrhythmia. Nature 2006; 440: 463-469.
5. Pillozzi S, Brizzi MF, Bernabei PA, Bartolozzi B, Caporale R, Basile V et al. VEGFR-1 (FLT-1), b1 integrin and hERG K+ channel form a macromolecular signaling complex in acute myeloid leukemia: Role in cell migration and clinical outcome. Blood 2007; 110: 1238-1250. (Pubitemid 47281422)
6. Arcangeli A, Pillozzi S, Becchetti A. Targeting ion channels in leukemias: A new challenge for treatment. Curr Med Chem 2012; 19: 683-696.
7. Pillozzi S, Masselli M, DeLorenzo E, Accordi B, Cilia E, Crociani O et al. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. Blood 2011; 117: 902-914.
8. London B, Trudeau MC, Newton KP, Beyer AK, Copeland NG, Gilbert DJ et al. Two isoforms of the mouse ether-A-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. Circ Res 1997; 81: 870-878. (Pubitemid 27467223)
9. Jones EM, Roti Roti EC, Wang J, Delfosse SA, Robertson GA. Cardiac IKr channels minimally comprise hERG 1a and 1b subunits. J Biol Chem 2004; 279: 44690-44694. (Pubitemid 39430878)
10. Crociani O, Guasti L, Balzi M, Becchetti A, Wanke E, Olivotto M et al. Cell cycledependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem 2003; 278: 2947-2955. (Pubitemid 36801200)
11. Conter V, Bartram CR, Valsecchi MG, Schrauder A, Panzer-Grümayer R, Möricke A et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 2010; 115: 3206-3214.
12. Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D et al. Early T-cell precursor leukaemia: A subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009; 10: 147-156.
13. Lastraioli E, Bencini L, Bianchini E, Romoli MR, Crociani O, Giommoni E et al. hERG1 channels and Glut-1 as independent prognostic indicators of worse outcome in Stage I and II colorectal cancer: A pilot study. Transl Oncol 2012; 5: 105-112.
14. Luo X, Xiao J, Lin H, Lu Y, Yang B, Wang Z. Genomic structure, transcriptional control, and tissue distribution of HERG1 and KCNQ1 genes. Am J Physiol Heart Circ Physiol 2008; 294: 1371-1380.
15. Tosello V, Ferrando AA. The NOTCH signaling pathway: Role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy. Ther Adv Hematol 2013; 4: 199-210.
16. Chiaretti S, Vitale A, Cazzaniga G, Orlando SM, Silvestri D, Fazi P et al. Clinico-biologic features of 5202 acute lymphoblastic leukemia patients enrolled in the Italian AIEOP and GIMEMA Protocols and stratified in age-cohorts. Haematologica 2013; 98: 1702-1710.